MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

21 Dec 2020 Evaluate

Glenmark Pharmaceuticals has informed that it has attached media release on 21st December 2020 titled ‘Glenmark Pharmaceuticals receives ANDA tentative approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg’ which is self explanatory.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1765.60
Dr. Reddys Labs. 1184.40
Cipla 1303.85
Lupin 1989.25
Zydus Lifesciences 1116.10
View more..